Tamoxifen Citrate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Tamoxifen Citrate drug offered from Mylan Pharmaceuticals Inc.. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Tamoxifen Citrate |
| SUBSTANCE NAME: | TAMOXIFEN CITRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-02-20 |
| END MARKETING DATE: | 0000-00-00 |
Tamoxifen Citrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tamoxifen Citrate from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2003-02-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-0144_3f51a3b6-14a3-44f4-8a60-9c9f3a9e8bee |
| PRODUCT NDC: | 0378-0144 |
| APPLICATION NUMBER: | ANDA074732 |
Other TAMOXIFEN CITRATE Pharmaceutical Manufacturers / Labelers:
